Add-On Technologies That Aim to Improve Oocyte Quality and Embryo Implantation Potential

Advancements in assisted reproductive technologies (ARTs) have led to the development of various add-on techniques aimed at improving oocyte quality and enhancing embryo implantation potential. These techniques target critical stages of both oocyte and embryo physiology, including oocyte growth and...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikos Petrogiannis, Maria Filippa, Kalliopi Chatzovoulou, Savvas Petrogiannis, Ioannis Filippas, Grigoris Grimbizis, Efstratios Kolibianakis, Katerina Chatzimeletiou
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/3/367
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Advancements in assisted reproductive technologies (ARTs) have led to the development of various add-on techniques aimed at improving oocyte quality and enhancing embryo implantation potential. These techniques target critical stages of both oocyte and embryo physiology, including oocyte growth and maturation, fertilization, chromosomal status, and embryo development. Key approaches involve the optimization of in vitro fertilization (IVF) protocols, recruiting capable follicles giving rise to dynamic oocytes to evolve, culture media supplementation, preimplantation genetic testing (PGT), and mitochondrial replacement therapy (MRT), all of which are designed to enhance oocyte competence through its function and metabolism. The use of PGT has been promising in selecting embryos suitable for transfer, thus optimizing implantation success. Emerging technologies, such as platelet-rich plasma treatment (PRP), time-lapse imaging (TLI), and hyaluronan-rich (HA) culture media, claim to improve ovarian rejuvenation and uterine receptivity, embryo selection, as well as embryo implantation potential, respectively. Evidence for certain add-on approaches remains limited, but ongoing research suggests that the use of such treatments may lead to increased clinical pregnancies and live birth rates, especially in poor-prognosis patients. The present review describes the current state of the add-on innovations, their mechanisms of action, as well as their possibilities to increase ART success rates.
ISSN:1010-660X
1648-9144